Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)
Boku, N., Ryu, M.-H., Kato, K., Chung, H.C., Minashi, K., Lee, K.-W., Cho, H., Kang, W.K., Komatsu, Y., Tsuda, M., Yamaguchi, K., Hara, H., Fumita, S., Azuma, M., Chen, L.-T., Kang, Y.-K.
Published in Annals of oncology (01.02.2019)
Published in Annals of oncology (01.02.2019)
Get full text
Journal Article
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Bang, Y.-J, Ruiz, E.Yañez, Van Cutsem, E., Lee, K.-W, Wyrwicz, L., Schenker, M., Alsina, M., Ryu, M.-H, Chung, H.-C, Evesque, L., Al-Batran, S.-E, Park, S.H., Lichinitser, M., Boku, N., Moehler, M.H., Hong, J., Xiong, H., Hallwachs, R., Conti, I., Taieb, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
Muro, K., Van Cutsem, E., Narita, Y., Pentheroudakis, G., Baba, E., Li, J., Ryu, M -H, Zamaniah, W I Wan, Yong, W -P, Yeh, K -H, Kato, K., Lu, Z., Cho, B.C., Nor, I.M., Ng, M., Chen, L -T, Nakajima, T.E., Shitara, K., Kawakami, H., Tsushima, T., Yoshino, T., Lordick, F., Martinelli, E., Smyth, E.C., Arnold, D., Minami, H., Tabernero, J., Douillard, J -Y
Published in Annals of oncology (01.01.2019)
Published in Annals of oncology (01.01.2019)
Get full text
Journal Article
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
Muro, K., Lordick, F., Tsushima, T., Pentheroudakis, G., Baba, E., Lu, Z., Cho, B.C., Nor, I.M., Ng, M., Chen, L -T, Kato, K., Li, J., Ryu, M -H, Zamaniah, W I Wan, Yong, W -P, Yeh, K -H, Nakajima, T.E., Shitara, K., Kawakami, H., Narita, Y., Yoshino, T., Van Cutsem, E., Martinelli, E., Smyth, E.C., Arnold, D., Minami, H., Tabernero, J., Douillard, J -Y
Published in Annals of oncology (01.01.2019)
Published in Annals of oncology (01.01.2019)
Get full text
Journal Article
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody–drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study
Gazzah, A., Bedard, P.L., Hierro, C., Kang, Y.-K., Abdul Razak, A., Ryu, M.-H., Demers, B., Fagniez, N., Henry, C., Hospitel, M., Soria, J.-C., Tabernero, J.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma
Shitara, K., Özgüroğlu, M., Bang, Y.-J., Di Bartolomeo, M., Mandalà, M., Ryu, M.-H., Caglevic, C., Chung, H.C., Muro, K., Van Cutsem, E., Kobie, J., Cristescu, R., Aurora-Garg, D., Lu, J., Shih, C.-S., Adelberg, D., Cao, Z.A., Fuchs, C.S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy
Kang, Y.-K., Ryu, M.-H., Park, S.H., Kim, J.G., Kim, J.W., Cho, S.-H., Park, Y.-I., Park, S.R., Rha, S.Y., Kang, M.J., Cho, J.Y., Kang, S.Y., Roh, S.Y., Ryoo, B.-Y., Nam, B.-H., Jo, Y.-W., Yoon, K.-E., Oh, S.C.
Published in Annals of oncology (01.05.2018)
Published in Annals of oncology (01.05.2018)
Get full text
Journal Article
Analysis of serum protein biomarkers, circulating tumor DNA, and dovitinib activity in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors
Yoo, C., Ryu, M.-H., Na, Y.S., Ryoo, B.-Y., Park, S.R., Kang, Y.-K.
Published in Annals of oncology (01.11.2014)
Published in Annals of oncology (01.11.2014)
Get full text
Journal Article
Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis
Kim, H.S., Kim, H.J., Kim, S.Y., Kim, T.Y., Lee, K.W., Baek, S.K., Ryu, M.H., Nam, B.H., Zang, D.Y.
Published in Annals of oncology (01.11.2013)
Published in Annals of oncology (01.11.2013)
Get full text
Journal Article
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)
Ryu, M.-H., Baba, E., Lee, K.H., Park, Y.I., Boku, N., Hyodo, I., Nam, B.-H., Esaki, T., Yoo, C., Ryoo, B.-Y., Song, E.-K., Cho, S.-H., Kang, W.K., Yang, S.H., Zang, D.Y., Shin, D.B., Park, S.R., Shinozaki, K., Takano, T., Kang, Y.-K.
Published in Annals of oncology (01.10.2015)
Published in Annals of oncology (01.10.2015)
Get full text
Journal Article
Impact of extranodal extension on prognosis in lymph node-positive gastric cancer
Lee, I.-S., Park, Y.-S., Ryu, M.-H., Song, M. J., Yook, J.-H., Oh, S.-T., Kim, B.-S.
Published in British journal of surgery (01.11.2014)
Published in British journal of surgery (01.11.2014)
Get full text
Journal Article
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum
YOON, D. H, RYU, M.-H, PARK, Y. S, LEE, H. J, LEE, C, RYOO, B.-Y, LEE, J.-L, CHANG, H.-M, KIM, T. W, KANG, Y.-K
Published in British journal of cancer (13.03.2012)
Published in British journal of cancer (13.03.2012)
Get full text
Journal Article
Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib
KANG, Y.-K, YOO, C, RYU, M.-H, RYOO, B.-Y, LEE, J. J, TAN, E, PARK, I, PARK, J. H, CHOI, Y. J, JO, J, RYU, J.-S
Published in British journal of cancer (29.10.2013)
Published in British journal of cancer (29.10.2013)
Get full text
Journal Article
A phase III study of adjuvant docetaxel, capecitabine and oxaliplatin triplet vs capecitabine and oxaliplatin doublet in patients with curatively resected stage IIIB or IV(M0) (AJCC 6th ed) gastric adenocarcinoma (TRIUMPH, KCSG ST14-05)
Ryu, M.-H., Zang, D.Y., Lee, K.-W., Shim, B.Y., Lee, M.H., Rha, S.Y., Kang, Y.-K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Predicting survival benefit of capecitabine plus cisplatin in patients with metastatic gastric cancer patients using quantitative proteomics
Yan, D., Ryu, M.-H., An, E., Park, Y.S., Na, H., Ma, J., Tian, Y., Cecchi, F., Hembrough, T., Kang, Y.-K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase II study of paclitaxel in patients with advanced gastrointestinal stromal tumor (GIST) after failure of at least both imatinib and sunitinib
Cho, H., Ryu, M.-H., Kim, B.J., Park, Y., Na, Y.-S., Ma, J., Beck, M.Y., Kang, Y.-K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Neutrophil-lymphocyte ratio (NLR) as an important prognostic factor for paclitaxel as a second line chemotherapy in advanced gastric cancer (AGC): Results from phase III DREAM study
Ryu, M.-H., Kim, J.H., Oh, S.C., Park, S., Kim, J.G., Kim, J.W., Cho, S.-H., Yoon, K.-E., Kang, Y.-K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article